E004

· Amphastar Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for E004, covering 2016-03-11 to 2018-07-31. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Efficacy and Safety of E004 in Children With Asthma [Phase 3]